Correction: Clinical Significance of Prior Ramucirumab Use on the Effectiveness of Nivolumab as the Third-Line Regimen in Gastric Cancer: A Multicenter Retrospective Study

Saved in:
Bibliographic Details
Main Authors: Yuka Obayashi, Shoichiro Hirata, Yoshiyasu Kono, Makoto Abe, Koji Miyahara, Masahiro Nakagawa, Michihiro Ishida, Yasuhiro Choda, Kenta Hamada, Masaya Iwamuro, Seiji Kawano, Yoshiro Kawahara, Motoyuki Otsuka
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-03-01
Series:Drugs - Real World Outcomes
Online Access:https://doi.org/10.1007/s40801-025-00485-y
Tags: Add Tag
No Tags, Be the first to tag this record!